Editorial: pharmacoepidemiology and pharmacovigilance post-marketing drug safety studies.

Página do item simplificado
dc.creatorZakir Khan
dc.creatorYusuf Karatas
dc.creatorAhmet Akici
dc.creatorMaria Auxiliadora Parreiras Martins
dc.creatorNafees Ahmad
dc.date.accessioned2026-03-04T14:34:49Z
dc.date.issued2024-08-20
dc.identifier.doi10.3389/fphar.2024.1473052
dc.identifier.issn1663-9812
dc.identifier.urihttps://hdl.handle.net/1843/1918
dc.languageeng
dc.publisherUniversidade Federal de Minas Gerais
dc.relation.ispartofFrontiers in pharmacology
dc.rightsAcesso aberto
dc.rightsAttribution-NonCommercial-NoDerivs 3.0 Brazilen
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/br/
dc.subjectFarmacovigilância
dc.subjectMedicamentos
dc.subjectSegurança do Paciente
dc.subjectEvento Adverso
dc.subject.otherPharmacovigilance
dc.subject.otherDrug
dc.subject.otherPatient safety
dc.subject.otherReal world data (RWD)
dc.subject.otherAdverse events
dc.titleEditorial: pharmacoepidemiology and pharmacovigilance post-marketing drug safety studies.
dc.typeArtigo de periódico
local.citation.epage3
local.citation.issue1473052
local.citation.spage1
local.citation.volume15
local.description.resumoThis article highlights the complementary roles of pharmacoepidemiology and pharmacovigilance in evaluating drug utilization, effectiveness, and safety in real-world settings. Drawing on 16 studies that used large pharmacovigilance databases and real-world data sources, the Research Topic explores adverse drug reactions, post-marketing safety surveillance, and signal detection across various medications and therapeutic areas. The findings emphasize the importance of continuous monitoring, integration of multiple data sources, and proactive safety assessment to ensure a favorable benefit–risk profile of marketed drugs. Overall, the collection reinforces the critical role of real-world evidence in supporting regulatory decisions and promoting rational drug use.
local.publisher.countryBrasil
local.publisher.departmentFAR - DEPARTAMENTO DE PRODUTOS FARMACÊUTICOS
local.publisher.initialsUFMG
local.subject.cnpqCIENCIAS DA SAUDE
local.url.externahttp://www.frontiersin.org/pharmacology/archive

Arquivos

Pacote original

Agora exibindo 1 - 2 de 2
Imagem de Miniatura
Nome:
license.txt
Tamanho:
2.15 KB
Formato:
Plain Text
Descrição:
License file
Baixar
Imagem de Miniatura
Nome:
Editorial_ Pharmacoepidemiology and pharmacovigilance post-marketing drug safety studies.pdf
Tamanho:
525.02 KB
Formato:
Adobe Portable Document Format
Baixar

Licença do pacote

Agora exibindo 1 - 1 de 1
Imagem de Miniatura
Nome:
license.txt
Tamanho:
2.07 KB
Formato:
Item-specific license agreed to upon submission
Descrição:
Baixar

Coleções

Artigo de Periódico

Logo UFMG